The Archive · A Source

COMPASS Pathways COMP006 Phase 3 TRD Trial

Compass Pathways IR 2025 ir.compasspathways.com/News--Events-/news/news-details/2025/Compass-Pathways-Successfully-Achieves-Primary-Endpoint-in-First-Phase-3-Trial-Evaluating-COMP360-Psilocybin-for-Treatment-Resistant-Depression/default.aspx